Allergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.

Similar documents
Asthma in Pediatric Patients. DanThuy Dao, D.O., FAAP. Disclosures. None

Evolution of asthma from childhood. Carlos Nunes Center of Allergy and Immunology of Algarve, PT

Asthma and Vocal Cord Dysfunction

Bronchial asthma. E. Cserháti 1 st Department of Paediatrics. Lecture for english speaking students 5 February 2013

Asthma: diagnosis and monitoring

Clinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy

Using Patient Characteristics to Individualize and Improve Asthma Care

Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ

7/7/2015. Somboon Chansakulporn, MD. History of variable respiratory symptoms. 1. Documented excessive variability in PFT ( 1 test)

Asthma Pathophysiology and Treatment. John R. Holcomb, M.D.

Air Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation.

SCREENING AND PREVENTION

Diagnosis, Treatment and Management of Asthma

Immunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine

The Link Between Viruses and Asthma

Pathology of Asthma Epidemiology

Asthma 2015: Establishing and Maintaining Control

COPD and Asthma: Similarities and differences Prof. Peter Barnes

Diagnosis and Management of Asthma in Children based on the British Thoracic Society and Scottish Intercollegiate Guidelines Network September 2016

Asthma COPD Overlap (ACO)

Allergy and Immunology Board Review Corner: Table of Contents

Exhaled Nitric Oxide: An Adjunctive Tool in the Diagnosis and Management of Asthma

COPYRIGHTED MATERIAL. Definition and Pathology CHAPTER 1. John Rees

Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air

(Asthma) Diagnosis, monitoring and chronic asthma management

Asthma. Rachel Miller, MD, FAAAAI Director Allergy and Immunology New York Presbyterian Hospital. Figure 1 Asthma Prevalence,

Life-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton

Distinction and Overlap. Allergy Dpt, 2 nd Pediatric Clinic, University of Athens

Systems Pharmacology Respiratory Pharmacology. Lecture series : General outline

The Asthma Guidelines: Diagnosis and Assessment of Asthma

Impact of Asthma in the U.S. per Year. Asthma Epidemiology and Pathophysiology. Risk Factors for Asthma. Childhood Asthma Costs of Asthma

WHEEZING IN INFANCY: IS IT ASTHMA?

DR REBECCA THOMAS CONSULTANT RESPIRATORY PHYSICIAN YORK DISTRICT HOSPITAL

Diagnostics Assessment Programme. Measurement of exhaled nitric oxide concentration in asthma; NIOX MINO and NObreath. Final scope

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?

Most common chronic disease in childhood Different phenotypes:

Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma

Defining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist

Asthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)

I have no perceived conflicts of interest or commercial relationships to disclose.

Asthma Management for the Athlete

RESPIRATORY CARE IN GENERAL PRACTICE

Asthma Update I have no professional or personal financial conflicts of interest to disclose.

Asthma Update Jennifer W. McCallister, MD, FACP, FCCP

Differential diagnosis

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children

NICE guideline Published: 29 November 2017 nice.org.uk/guidance/ng80

Recurrent Wheezing in Preschool Children. William Sheehan, MD Associate Professor of Pediatrics Division of Allergy and Immunology

Lecture Notes. Chapter 3: Asthma

COPD/ Asthma. Dr Heather Lewis Honorary Clinical Lecturer

Connecting Health & Housing: Asthma and the Home. Presented by: The California-Nevada Public Health Training Center

NG80. Asthma: diagnosis, monitoring and chronic asthma management (NG80)

Management of asthma in preschool children with inhaled corticosteroids and leukotriene receptor antagonists Leonard B. Bacharier

Asthma in the Athlete

Index. Note: Page numbers of article titles are in boldface type.

2. Diagnosis. 2.2 Asthma phenotypes. 2.1 Clinical features

Asthma Pathophysiology and Treatment

Robert Kruklitis, MD, PhD Chief, Pulmonary Medicine Lehigh Valley Health Network

Current Asthma Management: Opportunities for a Nutrition-Based Intervention

TARGET POPULATION Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS

Respiratory Pharmacology

Asthma: Chronic Management. Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015

Allergy and Immunology Review Corner: Chapter 71 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.

Wheeze and asthma in the very young

Speaker Disclosure. Identification and Diagnosis of Asthma. Definition of Asthma. Objectives 11/9/2017

Asthma. Don Hayes, Jr., MD, FAAP, FACP

Biologic Agents in the treatment of Severe Asthma

Bronchial asthma. MUDr. Mojmír Račanský Odd. Alergologie a klinické imunologie FNOL Ústav Imunologie LF UPOL

Prepared by Cyrus H. Nozad, MD, University of Tennessee and John Seyerle, MD, Ohio State University

Anti-allergic Effect of Bee Venom in An Allergic Rhinitis

Known Allergies: Shellfish. Symptoms: abdominal pain, nausea, diarrhea, or vomiting. congestion, trouble breathing, or wheezing.

Significance. Asthma Definition. Focus on Asthma

3002 Seminar. Problem-Based Learning: Evaluating and Managing the Patient with Recurrent Infections DO NOTE TURN THE PAGES UNTIL INSTRUCTED TO DO SO!

Abnormal Spirometry Medical Risk in Aviation Conference Royal Aeronautical Society, Dec 2017

Asthma By Mayo Clinic staff

Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma Full Report 2007

ASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides

Meeting the Challenges of Asthma

What is Asthma? Chronic disease of the airways that may cause Wheezing Breathlessness Chest tightness Night time or early morning coughing

ASTHMA ASTHMA DISEASE SUMMARY. Risk Factors

Clinical Practice Guideline: Asthma

DOWNLOAD PDF CH. 5. THE DIFFERENTIAL DIAGNOSIS OF ASTHMA IN CHILDHOOD

ADULT ASTHMA GUIDE SUMMARY. This summary provides busy health professionals with key guidance for assessing and treating adult asthma.

Sergio Bonini. Professor of Internal Medicine, Second University of Naples INMM-CNR, Rome, Italy.

Immunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine

Asthma and obesity, implications for airway inflammation and Bronchial Hyperresponsiveness

Outcome, classification and management of wheezing in preschool children Paul L.P. Brand

Asthma update Michigan Asthma Education Day Harvey L. Leo, MD

RESPIRATORY BLOCK. Bronchial Asthma. Dr. Maha Arafah Department of Pathology KSU

Get Healthy Stay Healthy

Respiratory Pharmacology PCTH 400 Asthma and β-agonists

Objectives. The Present and Future of Asthma: Birth Cohorts & Public Health Devon A. Greene, MD, MPH June 11, What is Asthma.

Primary Care Medicine: Concepts and Controversies Wed., February 17, 2010 Fiesta Americana Puerto Vallarta, Mexico Update on Asthma and COPD

2010 Health Press Ltd.

Diagnostics guidance Published: 2 April 2014 nice.org.uk/guidance/dg12

New Test ANNOUNCEMENT

Understanding Early Wheezing in the Development of Airflow Limitation in Children

An Insight into Allergy and Allergen Immunotherapy Co-morbidities of allergic disease

HealthPartners Care Coordination Clinical Care Planning and Resource Guide ASTHMA

Pulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?

Transcription:

Allergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al. Chapter 75: Approach to Infants and Children with Asthma Prepared by Martha K. Elias, Mayo Clinic, and John Seyerle, Ohio State University 1. A child with a wheeziing episode in the first three years of life is most likely to be classified in which of the following categories? A. Transient early wheezing B. Non-atopic persistent wheezing C. IgE-associated persistent wheezing D. Late-onset wheezers 2. Which of the following are risk factors for the transient early wheezing phenotype? A. Absence of school-age older children B. Female sex C. Allergen exposure D. Breast feeding 3. Non-atopic persistent wheezing is found in what percentage of children who wheezed before age 3? A. 10% B. 20% C. 30% D. 40% 4. Which of the following phenotypes generally presents after age 1 year? A. Transient early wheezing B. Non-atopic persistent wheezing C. IgE-associated persistent wheezing D. Non-wheezers 5. In the Tuscon study, sensitivity to what allergen was associated with increased likelihood of persistent asthma by age 11? A. Dust mite B. Bermuda grass C. Cockroach D. Alternaria 6. What percentage of children who wheeze in the first 3 years of life have resolution of their symptoms by 6 years of age according to the Tucson Children s Respiratory Study (TCRS)? A. 40% B. 50%

C. 60% D. 70% 7. IgE- associated/atopic persistent wheezing phenotype is associated with which risk factors? A. Female sex B. Seborrheic dermatitis C. Eosinophilia at 9 months D. Parental contact dermatitis 8. Which is a risk factor for fatal asthma? A. Two or more asthma hospitalizations for asthma in the past year B. Five or more emergency department visits for asthma in the past year C. Hospitalization or ED visit for asthma in the past week D. Use of >3 canisters per month of short acting bronchodilator (SABA) 9. Which asthma susceptibility gene codes for a metalloproteinase? A. T-bet B. GPRA C. DENND1B D. ADAM33 10. Which is the only childhood asthma treatment that can potentially modify existing allergic sensitization and secondarily reduce allergic asthma in regard to specific exposures? A. Anti- histamines B. Specific subcutaneous allergen immunotherapy C. Inhaled corticosteroids D. Environmental controls Answers 1. A, page 1320 Some 60% of children who wheeze in the first 3 years of life have resolution of their symptoms by 6 years of age. 2. C, page 1321 Risk factors for the transient early wheezing phenotype include maternal smoking, school-aged older siblings, day-care attendance, house-dust endotoxin, allergen exposure, male sex, and bottle-feeding. 3. B, page 1321 Non-atopic persistent wheezing is found in 20 percent of children who wheezed before age 3. 4. C, page 1321 Atopic persistent wheezing is present in 20% of children who wheeze before age 3, with

symptoms typically presenting after 1 year of age. 5. D, page 1321 In the Tuscon study, sensitivity to Alternaria was associated with increased likelihood of persistent asthma by age 11. 6. C, page 1321 Some 60% of children who wheeze in the first 3 years of life have resolution of their symptoms by 6 years of age according to the TCRS. 7. C, page 1321 Risk factors associated with atopic wheeze include male sex, parental asthma, atopic dermatitis, eosinophilia at 9 months, early sensitization to food or aeroallergen and a history of wheezing with lower respiratory tract infections. 8. A, page 1322 Risk factors for fatal asthma are: Two or more asthma hospitalizations for asthma in the past year, three or more emergency department visits for asthma in the past year, Hospitalization or ED visit for asthma in the past month, Use of >2 canisters per month of SABA. 9. D, page 1324 Polymorphisms in the asthma susceptibility gene ADAM33, which codes for a metalloproteinase, have a role in the inflammatory response or smooth muscle hypertrophy or hyperreactivity in asthma. C_7947 polymorphism in T-bet regulates Th1 lineage development and is associated with airway hyperresponsiveness. GPRA is a G- protein coupled receptor that binds to neuropeptide S and has been linked to asthma susceptibility and allergy in children and adults. DENND1B encodes a protein that interacts with the tumor necrosis factor (TNF) α receptor and represses inflammatory-cell TNF-receptor signaling. 10. B, page 1333 Specific subcutaneous allergen immunotherapy is the only childhood asthma treatment that can potentially modify existing allergic sensitization and secondarily reduce allergic asthma in regard to specific exposures. Allergy and Immunology Review Corner: Chapter 76 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al. Chapter 76: Approach to Adults with Asthma Prepared by John Seyerle, MD, Ohio State University 1. What is the approximate worldwide prevalence of asthma? A. 3 million

B. 15 million C. 150 million D. 300 million 2. Asthma is responsible for approximately how many deaths worldwide each year? A. 50,000 B. 150,000 C. 250,000 D. 350,000 3. Criteria for the diagnosis of asthma in adults generally include demonstration what minimum improvement in FEV1? A. 120mL B. 180mL C. 240mL D. 300mL 4. Diagnosis of asthma can also be made with what improvement in FEV1 over time following treatment with corticosteroids? A. 12% B. 15% C. 20% D. 24% 5. If using PEF instead of FEV1, what percentage increase following bronchodilator is considered suggestive of asthma? A. 12% B. 15% C. 20% D. 24% 6. Which of the following is the best method for diagnosing asthma and assessing control? A. Spirometry B. Physical exam C. Peak Expiratory Flow D. Chest Radiograph 7. For testing of airway responsiveness using methacholine or mannitol, the degree of responsiveness is measured as the dose required to induce what fall in FEV1? A. 12% B. 16% C. 20% D. 24% 8. Exhaled nitric oxide is a surrogate marker for what type of inflammation?

A. Eosinophilic B. Neutrophilic C. Bacterial D. Mast cell 9. What frequency of limitation of activity is allowed to occur to still call a person with asthma well-controlled? A. None B. Less than 2x per week C. Less than 2x per month D. Less than 2x per year 10. A person with asthma symptoms 3x per week, FEV1 of 85% predicted with a 15% increase following bronchodilator, and no exacerbations, nocturnal symptoms or limitations of activity would initially be classified as what type of asthma? A. Intermittent B. Mild persistent C. Moderate persistent D. Severe persistent Answers 1. D, page 1346 The approximate worldwide prevalence of asthma is 300 million. 2. C, page 1346 Asthma is responsible for approximately 250,000 deaths worldwide each year according to the World Health Organization. 3. B, page 1348 Criteria for the diagnosis of asthma generally include the demonstration of improvement in FEV1 of at least 12% post bronchodilator with a minimum of 180mL in adults. 4. C, page 1328 Diagnosis of asthma can also be made with 20% improvement in FEV1 over time following treatment with corticosteroids. 5. C, page 1348 If using PEF instead of FEV1, a 20% increase following bronchodilator is considered suggestive of asthma. 6. A, page 1350 Spirometry is the preferred method of measurement of airway obstruction. Physical exam is unreliable as it is only helpful during episodes of bronchoconstriction. Peak expiratory flow is effort dependent and may underestimate the degree of airflow limitation.

7. C, page 1350 For testing of airway responsiveness using methacholine or mannitol, the degree of responsiveness is measured as the dose required to induce a 20% fall in FEV1. 8. A, page 1350 Exhaled nitric oxide is a surrogate marker for eosinophilic inflammation. 9. A, page 1351 Any limitation of activity excludes calling asthma well-controlled. 10. B, page 1351 Mild persistent asthma is characterized by symptoms more than once a week but less than daily, nocturnal symptoms more than twice a month but less than once a week, FEV1 80%, or FEV1 variability <20%.